Outcome of Meeting of Board of Directors dated 14th August 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025 (Q1 FY26), along with the Secretarial Auditor's Report for FY24-25. Revenue from operations stood at Rs. 118.48 lakhs, down from Rs. 130.86 lakhs in Q1 FY25 (a decline of about 9.5%). However, the company swung back to a net profit of Rs. 7.32 lakhs compared to a loss of Rs. 14.09 lakhs in the same quarter last year, translating to EPS of Rs. 1.83 versus a negative Rs. 3.52. The consolidated results include two associate companies - Vidarbha Bidi Limited and Tip Top Health Zone Private Limited. The statutory auditors (M/s Daga Chaturmutha) issued an unmodified limited review report on both standalone and consolidated results with no qualifications or observations.
A return to profitability in Q1 FY26 after consecutive losses in FY25 is a positive signal for shareholders, though the underlying revenue decline suggests top-line pressure remains. Investors should monitor whether the profit recovery sustains and whether the revenue contraction reverses in upcoming quarters.